727 C (Glipizide and Metformin 2.5 mg / 250 mg)

Pill imprint 727 C has been identified as Glipizide and metformin hydrochloride 2.5 mg / 250 mg.

Glipizide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glipizide/metformin 2.5 mg / 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Glipizide and metformin hydrochloride

Imprint:

727 C

Strength:

2.5 mg / 250 mg

Color:

Peach

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Antidiabetic combinations

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Caraco Pharmaceutical Laboratories,Ltd.

National Drug Code (NDC):

57664-0727

Inactive Ingredients:

microcrystalline cellulose
povidone
croscarmellose sodium
polyethylene glycol
magnesium stearate
polyvinyl alcohol
titanium dioxide
polyethylene glycol 3350
magnesium silicate
lecithin
ferric oxide yellow
ferric oxide red

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.